Syllabus for Advanced Drug Delivery

Avancerade principer för läkemedelsformulering


  • 7.5 credits
  • Course code: 3FG011
  • Education cycle: Second cycle
  • Main field(s) of study and in-depth level: Pharmaceutical Sciences A1N

    Explanation of codes

    The code indicates the education cycle and in-depth level of the course in relation to other courses within the same main field of study according to the requirements for general degrees:

    First cycle

    • G1N: has only upper-secondary level entry requirements
    • G1F: has less than 60 credits in first-cycle course/s as entry requirements
    • G1E: contains specially designed degree project for Higher Education Diploma
    • G2F: has at least 60 credits in first-cycle course/s as entry requirements
    • G2E: has at least 60 credits in first-cycle course/s as entry requirements, contains degree project for Bachelor of Arts/Bachelor of Science
    • GXX: in-depth level of the course cannot be classified

    Second cycle

    • A1N: has only first-cycle course/s as entry requirements
    • A1F: has second-cycle course/s as entry requirements
    • A1E: contains degree project for Master of Arts/Master of Science (60 credits)
    • A2E: contains degree project for Master of Arts/Master of Science (120 credits)
    • AXX: in-depth level of the course cannot be classified

  • Grading system: Fail (U), Pass (G), Pass with distinction (VG)
  • Established: 2020-10-20
  • Established by: The Educational Board of Pharmacy
  • Revised: 2022-03-08
  • Revised by: The Educational Board of Pharmacy
  • Applies from: Autumn 2023
  • Entry requirements:

    150 credits, including 120 credits from courses in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) pharmaceutics and pharmacokinetics 15 credits or (2) Molecular Biopharmacy 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.

  • Responsible department: Department of Pharmacy

Learning outcomes

After course completion, the student should:

  • illustrate the role of drug delivery systems during drug development in the pharmaceutical industry
  • judge which transport mechanisms and barriers that govern the uptake of drugs via different administration routes
  • analyse and discuss challenges associated with the choice of drug delivery system and administration route based on the molecular properties of the drug
  • Explain, construct and critically evaluate common drug delivery strategies
  • Account for regulatory requirements during the development of drug delivery systems and dosage forms
  • Utilize, assess and summarize in written and orally present relevant scientific literature within drug delivery systems, using correct English.


The course gives a deep understanding of the molecular properties of drugs and how they affect the choice of drug delivery system and administration route. Furthermore, it describes how pharmacokinetic and pharmacodynamic models are used to predict the bioavailability and effect of drugs for different administration routes. We relate barrier properties (physiological, biochemical, chemical), transport proteins and enzymes to their importance for drug delivery via different administration routes. This includes cell culture models to study mechanisms of drug transport across biological barriers. We study intracellular drug delivery and subcellular drug distribution and how to choose appropriate drug delivery systems so that drugs can cross these barriers. The course will furthermore cover formulation principles for different administration routes; pulmonary, parenteral, oral, dermal and vaginal. This includes colloidal and semi-solid systems (e.g. liposomes, gels), solid mesoporous carriers, nanocarriers and pro-drug strategies as well as advanced characterization methods for drug delivery systems in silico and in vitro. Finally, we will discuss regulatory aspects when choosing a drug delivery system and dosage form.


Teaching is in the form of lectures, discussion seminars and a literature study. Certain parts of the instruction will be carried out digitally.

The course is given in English.

Discussion seminars and the literature study are compulsory.


A written examination is conducted at the end of the course. The following is required to pass the course: passed written examination (6 hp) and passed on compulsory parts of the course (literature study: 1 hp, discussion seminars: 0.5 hp).

If special reasons apply, the examiner may make exceptions from the described examination and allow a student to be assessed differently. An example of special reasons might be a certificate regarding special pedagogical support from the coordinator of the university.

Syllabus Revisions

Reading list

Reading list

Applies from: Autumn 2022

Some titles may be available electronically through the University library.

  • Wang, Binghe; Hu Drug Delivery [Elektronisk resurs]

    Wiley, 2016

    Chapter 1-14

    Find in the library